Jane Street Group, LLC Amgen Inc Transaction History

Jane Street Group, LLC

$88.2 Billion
Q2 2024

A detailed history of Jane Street Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 422,292 shares of AMGN stock, worth $133 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

422,292

Previous 257,659 63.9%

Holding current value

$133 Million

Previous $73.3 Million 80.11%

% of portfolio

0.15%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $43.3 Million - $52.6 Million	164,633 Added 63.9%	422,292 $132 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $31.9 Million - $38.5 Million	-118,556 Reduced 31.51%	257,659 $73.3 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $30.3 Million - $34.2 Million	-118,615 Reduced 23.97%	376,215 $108 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $85.1 Million - $106 Million	389,147 Added 368.22%	494,830 $133 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $13.2 Million - $15.6 Million	61,498 Added 139.18%	105,683 $23.5 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $11.5 Million - $14 Million	-50,915 Reduced 53.54%	44,185 $10.7 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $12.3 Million - $15.6 Million	53,497 Added 128.59%	95,100 $25 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $70.5 Million - $79.5 Million	-314,095 Reduced 88.3%	41,603 $9.38 Million
Q2 2022 Aug 16, 2022	BUY	$230.71 - $256.74 $65.3 Million - $72.7 Million	283,190 Added 390.56%	355,698 $86.5 Million
Q1 2022 May 17, 2022	BUY	$219.27 - $242.57 $1.49 Million - $1.65 Million	6,812 Added 10.37%	72,508 $17.5 Million
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $4.45 Million - $5.1 Million	22,393 Added 51.71%	65,696 $14.8 Million
Q3 2021 Nov 16, 2021	SELL	$212.27 - $248.7 $18.6 Million - $21.8 Million	-87,595 Reduced 66.92%	43,303 $9.21 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $4.69 Million - $5.2 Million	20,061 Added 18.1%	130,898 $31.9 Million
Q1 2021 May 18, 2021	BUY	$221.91 - $258.6 $12.1 Million - $14.1 Million	54,580 Added 97.02%	110,837 $27.6 Million
Q4 2020 Feb 17, 2021	SELL	$216.38 - $257.67 $1.14 Million - $1.36 Million	-5,276 Reduced 8.57%	56,257 $12.9 Million
Q3 2020 Nov 17, 2020	BUY	$234.65 - $260.95 $8.41 Million - $9.35 Million	35,846 Added 139.55%	61,533 $15.6 Million
Q2 2020 Aug 17, 2020	SELL	$197.81 - $242.74 $6.65 Million - $8.17 Million	-33,640 Reduced 56.7%	25,687 $6.06 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $2.89 Million - $3.83 Million	-15,858 Reduced 21.09%	59,327 $12 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $9.53 Million - $12.2 Million	50,354 Added 202.79%	75,185 $18.1 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $2.68 Million - $3.21 Million	-15,376 Reduced 38.24%	24,831 $4.81 Million
Q2 2019 Aug 15, 2019	SELL	$166.7 - $195.41 $10.7 Million - $12.5 Million	-64,137 Reduced 61.47%	40,207 $7.41 Million
Q1 2019 May 16, 2019	BUY	$180.87 - $203.88 $3.68 Million - $4.15 Million	20,343 Added 24.22%	104,344 $19.8 Million
Q4 2018 Feb 15, 2019	BUY	$178.4 - $208.25 $2.2 Million - $2.57 Million	12,354 Added 17.24%	84,001 $16.4 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $551,793 - $622,074	-2,978 Reduced 3.99%	71,647 $14.9 Million
Q2 2018 Aug 15, 2018	BUY	$166.05 - $186.51 $9.29 Million - $10.4 Million	55,966 Added 299.94%	74,625 $13.8 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $6.67 Million - $7.79 Million	-39,367 Reduced 67.84%	18,659 $3.18 Million
Q4 2017 Feb 15, 2018	SELL	$168.79 - $188.59 $12.1 Million - $13.5 Million	-71,521 Reduced 55.21%	58,026 $10.1 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $21.7 Million - $24.7 Million	129,547	129,547 $24.2 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Amgen Inc Transaction History